Origin of ovarian cancer from benign cysts

被引：8
|
作者：
Dal Maso, L
Canzonieri, V
Talamini, R
Franceschi, S
La Vecchia, C
机构：
[1] Mario Negri Inst Pharmacol Res, Lab Gen Epidemiol, I-20157 Milan, Italy
[2] Int Agcy Res Canc, Field & Intervent Studies Unit, F-69372 Lyon, France
[3] Univ Milan, Ist Stat Med & Biometria, I-20122 Milan, Italy
[4] Ctr Riferimento Oncol, I-33081 Aviano, PN, Italy
来源：
EUROPEAN JOURNAL OF CANCER PREVENTION | 2001年 / 10卷 / 02期
关键词：
ovarian cancer; cysts; epidemiology; oral contraceptives; risk;
D O I：
10.1097/00008469-200104000-00016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In a case-control study of 1031 epithelial ovarian cancers and 2311 controls conducted in Italy, 56 cases and 116 controls reported history of benign ovarian cysts, corresponding to a relative risk of 1.3 (95% confidence interval = 0.9-1.8). In a subset of 255 histologically reviewed cases, mucinous and endometrioid ovarian neoplasms and neoplasms of stage I or II arose more frequently from cysts, while use of oral contraceptives or parity were not significantly related to history of ovarian cysts. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码：197 / 199
页数：3
相关论文
共 50 条
  • [1] Benign ovarian cysts and breast cancer risk
    Bosetti, Cristina
    Scotti, Lorenza
    Negri, Eva
    Talamini, Renato
    Levi, Fabio
    Franceschi, Silvia
    Montella, Maurizio
    Giacosa, Attilio
    La Vecchia, Carlo
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (07) : 1679 - 1682
  • [2] Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening
    Crayford, TJB
    Campbell, S
    Bourne, TH
    Rawson, HJ
    Collins, WP
    LANCET, 2000, 355 (9209): : 1060 - 1063
  • [3] SERUM CHEMOKINE LEVELS IN PATIENTS WITH OVARIAN CANCER OR BENIGN OVARIAN CYSTS
    Nowak, M.
    Glowacka, E.
    Janas, L.
    Wilczynski, J. R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1458 - 1458
  • [4] CYTOMEGALY IN BENIGN OVARIAN CYSTS
    SCHUGER, L
    SIMON, A
    OKON, E
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1986, 110 (10) : 928 - 929
  • [5] Fibrinolytic proteins and inhibitors in ovarian cancer tissues compared with benign ovarian cysts
    Koh, SCL
    Tham, KF
    Khalil, R
    Lim, FK
    Oei, PL
    Ratnam, SS
    Chua, SE
    Yuen, WK
    Ng, BL
    THROMBOSIS AND HAEMOSTASIS, 1999, : 170 - 170
  • [6] DISTINCTION OF BENIGN FROM MALIGNANT OVARIAN CYSTS BY ULTRASOUND
    MEIRE, HB
    FARRANT, P
    GUHA, T
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1978, 85 (12): : 893 - 899
  • [7] Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer
    Bischof, A
    Briese, V
    Richter, DU
    Bergemann, C
    Friese, K
    Jeschke, U
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1639 - 1644
  • [8] WHY REMOVE BENIGN OVARIAN CYSTS
    MENDELSOHN, RS
    RN MAGAZINE, 1984, 47 (02): : 67 - 67
  • [9] Lateral distribution of benign ovarian cysts
    Ferrero, S
    Ragni, N
    Fulcheri, E
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 89 (02) : 150 - 151
  • [10] Aspirating benign and borderline ovarian cysts
    Greenebaum, E
    LABORATORY MEDICINE, 1996, 27 (08) : 538 - 541
12345